Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa

A 64-year-old patient developed a widespread autoimmune mucocutaneous blistering disease 3 weeks after the initiation of the anti-programmed death-1 (anti-PD-1) pembrolizumab therapy administered for a locally advanced cutaneous squamous cell carcinoma (SCC) of the buttocks arising from hidradenitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatim, Ahmad, Bohelay, Gérôme, Grootenboer-Mignot, Sabine, Prost-Squarcioni, Catherine, Alexandre, Marina, Le Roux-Villet, Christelle, Martin, Antoine, Maubec, Eve, Caux, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848154/
https://www.ncbi.nlm.nih.gov/pubmed/31750309
http://dx.doi.org/10.3389/fmed.2019.00249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848154/
https://www.ncbi.nlm.nih.gov/pubmed/31750309
http://dx.doi.org/10.3389/fmed.2019.00249

Ejemplares similares